Axogen Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $5.62
- Today's High:
- $5.82
- Open Price:
- $5.76
- 52W Low:
- $7.2
- 52W High:
- $13.66
- Prev. Close:
- $5.82
- Volume:
- 257073
Company Statistics
- Market Cap.:
- $373.50 million
- Book Value:
- 2.278
- Revenue TTM:
- $144.24 million
- Operating Margin TTM:
- -17.84%
- Gross Profit TTM:
- $114.44 million
- Profit Margin:
- -17.02%
- Return on Assets TTM:
- -8.3%
- Return on Equity TTM:
- -24.38%
Company Profile
Axogen Inc had its IPO on 1990-03-27 under the ticker symbol AXGN.
The company operates in the Healthcare sector and Medical Devices industry. Axogen Inc has a staff strength of 394 employees.
Stock update
Shares of Axogen Inc opened at $5.76 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $5.62 - $5.82, and closed at $5.65.
This is a -2.92% slip from the previous day's closing price.
A total volume of 257,073 shares were traded at the close of the day’s session.
In the last one week, shares of Axogen Inc have slipped by -10.32%.
Axogen Inc's Key Ratios
Axogen Inc has a market cap of $373.50 million, indicating a price to book ratio of 4.5561 and a price to sales ratio of 3.3809.
In the last 12-months Axogen Inc’s revenue was $144.24 million with a gross profit of $114.44 million and an EBITDA of $-22629000. The EBITDA ratio measures Axogen Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Axogen Inc’s operating margin was -17.84% while its return on assets stood at -8.3% with a return of equity of -24.38%.
In Q1, Axogen Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 18.2%.
Axogen Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-0.61 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Axogen Inc’s profitability.
Axogen Inc stock is trading at a EV to sales ratio of 3.5589 and a EV to EBITDA ratio of -20.3497. Its price to sales ratio in the trailing 12-months stood at 3.3809.
Axogen Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $189.47 million
- Total Liabilities
- $21.24 million
- Operating Cash Flow
- $-786000.00
- Capital Expenditure
- $4.56 million
- Dividend Payout Ratio
- 0%
Axogen Inc ended 2024 with $189.47 million in total assets and $0 in total liabilities. Its intangible assets were valued at $189.47 million while shareholder equity stood at $97.51 million.
Axogen Inc ended 2024 with $4.70 million in deferred long-term liabilities, $21.24 million in other current liabilities, 428000.00 in common stock, $-266654000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $7.71 million and cash and short-term investments were $37.87 million. The company’s total short-term debt was $1,050,000 while long-term debt stood at $45.93 million.
Axogen Inc’s total current assets stands at $88.70 million while long-term investments were $0 and short-term investments were $30.16 million. Its net receivables were $22.28 million compared to accounts payable of $20.19 million and inventory worth $19.85 million.
In 2024, Axogen Inc's operating cash flow was $-786000.00 while its capital expenditure stood at $4.56 million.
Comparatively, Axogen Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $5.65
- 52-Week High
- $13.66
- 52-Week Low
- $7.2
- Analyst Target Price
- $17.4
Axogen Inc stock is currently trading at $5.65 per share. It touched a 52-week high of $13.66 and a 52-week low of $13.66. Analysts tracking the stock have a 12-month average target price of $17.4.
Its 50-day moving average was $7.39 and 200-day moving average was $8.94 The short ratio stood at 4.44 indicating a short percent outstanding of 0%.
Around 494.9% of the company’s stock are held by insiders while 7758.9% are held by institutions.
Frequently Asked Questions About Axogen Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
AxoGen, Inc., together with its subsidiaries, develops and markets technologies for peripheral nerve regeneration and repair worldwide. The company’s products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.